One hundred and four adult patients with cystic fibrosis were evaluated for the presence of liver disease as defined by abnormal liver function tests of six months' duration, histological evidence of fibrosis or cirrhosis, or the presence of portal hypertension, or both. Twenty patients fulfilled these criteria and were evaluated further for the presence of biliary tract abnormalities with biliary scintigraphy using 99Tc diisopropylphenylcarboxymethyl iminodiacetic acid (DISIDA) and endoscopic retrograde cholangiography. Clearance of 99Tc DISIDA from the liver and biliary tree was diminished at 45 (E45) and 60 (E60) minutes in the patients with liver disease compared with those without liver disease;
carboxymethyl iminodiacetic acid (DISIDA) and endoscopic retrograde cholangiography. Clearance of 99Tc DISIDA from the liver and biliary tree was diminished at 45 (E45) and 60 (E60) minutes in the patients with liver disease compared with those without liver disease; E45=37*8% and 65-8%, p<001; E60=48*2% and 77*5%, p<001 respectively. Serial analogue images of the extrahepatic biliary tree were consistent with common bile duct obstruction with retention of DISIDA and tapering of the common bile duct in seven of 18 patients with and two of 10 patients without liver disease. Endoscopic retrograde cholangiography showed changes consistant with sclerosing cholangitis, with beading and stricturing of the intrahepatic ducts in 12 of the 14 patients. In all 14 patients, including those in whom biliary scintigraphy had suggested obstruction, no abnormality of the common bile duct was identified. These results indicate that abnormalities of the bile ducts in patients with cystic fibrosis related liver disease are confined to the intrahepatic biliary tree and that common bile duct strictures do not contribute to either the progression or development of liver disease in these patients.
The improvement in prognosis for patients with cystic fibrosis in recent decades can be largely attributed to the major advances in the management of bronchopulmonary sepsis and malnutrition.'-3 Many cystic fibrosis patients are currently surviving into the fourth decade, and with this improved survival it has been recognised that the prevalence of cystic fibrosis related liver disease increases with advancing years ranging from 0-5-8-0% in children to 5-20% in adults. 4 The development of liver disease in cystic fibrosis has been attributed to the inspissation of tenacious secretions within small bile ductules, with the subsequent development of progressive cholestasis, focal periportal biliary fibrosis, and eventually multilobular biliary cirrhosis and portal hypertension.5`8 Strictures of the extrahepatic biliary tree have been suggested as a possible aetiological factor in the development of cystic fibrosis related liver disease in previous reports,9-" and in one study common bile duct strictures were detected in over 90% of patients with hepatic dysfunction.'2 A subsequent study, however, highlighted the structural abnormalities within the intrahepatic biliary tree and showed a relatively low prevalence of common bile duct strictures in these patients. '3 Since common bile duct strictures may be a factor in the development of liver disease in cystic fibrosis, surgical correction of which might prevent progression of the disease,'2 we have evaluated the intra-and extrahepatic biliary tree in a group of patients with cystic fibrosis related liver disease. 1  486  2  204  3  553  4  328  5  296  6  399  7  260  8  188  9  194  10  191  11  389   12  218  13  497  14  130  15  436  16  425  17  456  18  208  19  162  20  253 t GT SNT PTR Histology PHT (SIV)   289  70  459  266   51   169  46  104  73  406  124  33  175  42  47  41  146  47  64  45   47  37  71  45  86  22  21  22  23  26  35  16  104  10  12  18  56 Hepatic uptake of DISIDA was delayed in the patients with liver disease, the Tmax in these patients was mean (SEM) 15-6 (2 1) minutes compared with 9 0 (0 5) minutes in the patients without liver disease (p=0 01) (Fig 1) . There were also significant differences with regard to the percentage clearance of DISIDA from the liver and biliary tree at 45 and 60 minutes in the two patient groups. At 45 minutes, 37-8 (4 9)% of DISIDA had been cleared from the liver and biliary tree in the patients with liver disease compared with 65 8 (4 6)% in those without liver disease (p<001). Similarly, at 60 minutes 48-2 (5 0)% and 77-5 (2 9)% of DISIDA was cleared from the liver in the patients with and without liver disease respectively (p<001) (Fig 1) of 18 patients with liver disease (39%) and in two of 10 patients without liver disease (20%) ( Table  III) . These differences were not statistically significant using X2 analysis.
ENDOSCOPIC RETROGRADE CHOLANGIOGRAPHY
Abnormalities of the intrahepatic ducts were noted in 12 of the 14 patients (85%). The changes varied from minor irregularity and tapering of the smaller intrahepatic biliary radicals to stricturing, beading, and segmental dilatation of the large bile ducts (Table IV) . Strictures of the extrahepatic biliary tree were not observed. Two patients had common bile duct calculi, both of whom were symptomatic. A discrepancy between the findings at endoscopic cholangiography and biliary scintigraphy was noted in patients who had undergone both examinations. In seven patients serial analogue images had been interpreted as indicating the presence of a common bile duct stricture on the basis of a tapering appearance and retention of isotope. Endoscopic cholangiography was performed in four of these patients and showed no evidence of a common bile duict stricture or retention of contrast within the biliary tree. An example of the discordant findings at cholangiography and scintigraphy is illustrated in Figure 2 which shows retention of DISIDA within the biliary tree and tapering of the common bile duct in a 15 year old girl with cirrhosis and portal hypertension in whom retrograde cholangiography showed a normal extrahepatic biliary tree. In previous studies using serial analogue images of the biliary tree after intravenous administration of DISIDA, retention of the radiolabelled tracer in the extrahepatic biliary tree had been interpreted as indicating the presence of distal common bile duct obstruction.'2 However, as illustrated by our findings, retention of DISIDA within the extrahepatic biliary tree can occur in the absence of cholangiographically evident common bile duct obstruction. Thus, in four of the patients in whom biliary scintigraphy suggested extrahepatic biliary obstruction, cholangiographic findings showed common bile ducts of normal calibre without stricture formation and free flow of contrast into the duodenum. Moreover, in the two patients with common bile duct stones who had undergone sphincterotomy and stone extraction, the biliary scintigraphic findings suggested common bile duct obstruction. Finally, in a significant number of the patients without liver disease, the scintigraphic findings were consistent with extrahepatic duct obstruction. These observations indicate that while biliary scintigraphy may be a valuable diagnostic procedure in establishing common bile duct obstruction in most situations, its value in this regard in patients with cystic fibrosis is questionable. It is possible that factors other than mechanical obstruction are responsible for the retention of radioisotope. Thus, biliary hypomotility and stasis or adherence of DISIDA to abnormally viscid mucus within the biliary tree, or both, could result in prolonged retention and mimic mechanical obstruction.
The results of the present study clearly show that extrahepatic biliary strictures are not a prevalent finding or a factor in the pathogenesis or progression of liver disease in patients with cystic fibrosis. 
